Johnson CA - Search Results

1

Baseline visual field characteristics in the ocular hypertension treatment study.

Johnson CA, Keltner JL, Cello KE, Edwards M, Kass MA, Gordon MO, Budenz DL, Gaasterland DE, Werner E; Ocular Hypertension Study Group. Johnson CA, et al. Ophthalmology. 2002 Mar;109(3):432-7. doi: 10.1016/s0161-6420(01)00948-4. Ophthalmology. 2002. PMID: 11874743 Clinical Trial.

2

Development of efficient threshold strategies for frequency doubling technology perimetry using computer simulation.

Turpin A, McKendrick AM, Johnson CA, Vingrys AJ. Turpin A, et al. Among authors: johnson ca. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):322-31. Invest Ophthalmol Vis Sci. 2002. PMID: 11818373

3

Mechanisms isolated by frequency-doubling technology perimetry.

Anderson AJ, Johnson CA. Anderson AJ, et al. Among authors: johnson ca. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):398-401. Invest Ophthalmol Vis Sci. 2002. PMID: 11818383

4

Short-wavelength sensitivity deficits in patients with migraine.

McKendrick AM, Cioffi GA, Johnson CA. McKendrick AM, et al. Among authors: johnson ca. Arch Ophthalmol. 2002 Feb;120(2):154-61. doi: 10.1001/archopht.120.2.154. Arch Ophthalmol. 2002. PMID: 11831917

5

Spatial and temporal processing of threshold data for detection of progressive glaucomatous visual field loss.

Spry PG, Johnson CA, Bates AB, Turpin A, Chauhan BC. Spry PG, et al. Among authors: johnson ca. Arch Ophthalmol. 2002 Feb;120(2):173-80. doi: 10.1001/archopht.120.2.173. Arch Ophthalmol. 2002. PMID: 11831919

6

Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.

Turpin A, McKendrick AM, Johnson CA, Vingrys AJ. Turpin A, et al. Among authors: johnson ca. Invest Ophthalmol Vis Sci. 2002 Mar;43(3):709-15. Invest Ophthalmol Vis Sci. 2002. PMID: 11867588

7

Recent developments in automated perimetry in glaucoma diagnosis and management.

Johnson CA. Johnson CA. Curr Opin Ophthalmol. 2002 Apr;13(2):77-84. doi: 10.1097/00055735-200204000-00004. Curr Opin Ophthalmol. 2002. PMID: 11880719 Review.

8

Identification of progressive glaucomatous visual field loss.

Spry PG, Johnson CA. Spry PG, et al. Among authors: johnson ca. Surv Ophthalmol. 2002 Mar-Apr;47(2):158-73. doi: 10.1016/s0039-6257(01)00299-5. Surv Ophthalmol. 2002. PMID: 11918896 Review.

9

Sensitivity and specificity of the Swedish interactive threshold algorithm for glaucomatous visual field defects.

Budenz DL, Rhee P, Feuer WJ, McSoley J, Johnson CA, Anderson DR. Budenz DL, et al. Among authors: johnson ca. Ophthalmology. 2002 Jun;109(6):1052-8. doi: 10.1016/s0161-6420(02)01047-3. Ophthalmology. 2002. PMID: 12045043

10

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. Kass MA, et al. Among authors: johnson ca. Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30. doi: 10.1001/archopht.120.6.701. Arch Ophthalmol. 2002. PMID: 12049574 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,410 results

Search Page